Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      NEONATAL necrotizing enterocolitis; IMMUNOGLOBULIN G; THERAPEUTIC use of immunoglobulins; TREATMENT of premature infant diseases; THERAPEUTICS
    • Abstract:
      Interpretation: Supplementation of enteral feeds with human IgG does not reduce necrotising enterocolitis. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)